Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Hoffmann

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
NPJ Vaccines|September 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccinationElena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in SwitzerlandMarius Zeeb, Burcu Tepekule, Katharina Kusejko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 23, 2026
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findingsRichard B Warren, Melinda Gooderham, Edward Lain, et al.
The Journal of Infectious Diseases|March 6, 2019
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic DiseasesKatharina Kusejko, Nadine Bachmann, Sandra E Chaudron, et al.
The Journal of Infectious Diseases|February 14, 2019
Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up EraLuisa Salazar-Vizcaya, Roger D Kouyos, Karin J Metzner, et al.
Trials|July 3, 2024
POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients (POSITiVE) II-study protocol of a randomized clinical trialMartin H Bernardi, Dominique Bettex, Laura A Buiteman-Kruizinga, et al.
Plos Pathogens|August 8, 2024
Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screenNadia Neuner-Jehle, Marius Zeeb, Christian W Thorball, et al.
Plos Pathogens|August 13, 2025
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1Marius Zeeb, Katharina Kusejko, Sonja Hartnack, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
NPJ Vaccines|September 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccinationElena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in SwitzerlandMarius Zeeb, Burcu Tepekule, Katharina Kusejko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 23, 2026
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findingsRichard B Warren, Melinda Gooderham, Edward Lain, et al.
The Journal of Infectious Diseases|March 6, 2019
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic DiseasesKatharina Kusejko, Nadine Bachmann, Sandra E Chaudron, et al.
The Journal of Infectious Diseases|February 14, 2019
Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up EraLuisa Salazar-Vizcaya, Roger D Kouyos, Karin J Metzner, et al.
Trials|July 3, 2024
POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients (POSITiVE) II-study protocol of a randomized clinical trialMartin H Bernardi, Dominique Bettex, Laura A Buiteman-Kruizinga, et al.
Plos Pathogens|August 8, 2024
Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screenNadia Neuner-Jehle, Marius Zeeb, Christian W Thorball, et al.
Plos Pathogens|August 13, 2025
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1Marius Zeeb, Katharina Kusejko, Sonja Hartnack, et al.
Pageof 15